Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.38 billion.

For earnings history and earnings-related data on Boston Scientific (BSX) click here.

Earnings Guidance

Boston Scientific (BSX) PT Raised to $32 at CitiFebruary 5, 2018 6:27 AM Boston Scientific (BSX) PT Raised to $35 at Needham & CompanyFebruary 1, 2018 3:28 PM Boston Scientific (BSX) PT Raised to $31 at StifelFebruary 1, 2018 2:46 PM Boston Scientific (BSX) PT Raised to $28.50 at Evercore ISIFebruary 1, 2018 12:45 PM Boston Scientific Announces Results for Fourth Quarter and Full Year 2017February 1, 2018 6:30 AM